|
(V1290) |
Sphingolipids improve vascular barrier function and systemic blood pressure by reducing pericyte loss during LPS-mediated inflammation |
| |
|
F. Abdel Rahman, T. Ziegler, S. d'Almeida, R. Hinkel, K.-L. Laugwitz, C. Kupatt (München) |
|
|
Diskussion |
|
(V1291) |
Identification of a biased angiotensin II receptor type 1-ligand that attenuates atherosclerosis through selective inhibition of Gq-mediated signaling |
| |
|
B. Moahamed, A. Krull, K. Wöltje, V. Stangl, K. Stangl, T. Althoff (Berlin) |
|
|
Diskussion |
|
(V1292) |
Evaluation of an anti-tumor necrosis factor-α therapy in a mouse model of experimental atherosclerosis |
| |
|
J. Schütt, R. Oberoi, A.-K. Vlacil, F. Schösser, H. Schütt, U. J. Tietge, B. Schieffer, K. Grote (Marburg; Groningen, NL) |
|
|
Diskussion |
|
(V1293) |
DNA-PK mediates IKKg/NEMO nucleocytoplasmic shuttling and NF-kappaB activation in response to genotoxic stress |
| |
|
N. Leschowski, S. Weinert, R. Braun-Dullaeus, S. Medunjanin (Magdeburg) |
|
|
Diskussion |
|
(V1294) |
Septic hypercirculation mediated by the VEGF-Receptor adaptor protein TSAd |
| |
|
M. Asadi, T. Ziegler, D. Bongiovanni, S. d'Almeida, R. Hinkel, M. Hellström, K.-L. Laugwitz, C. Kupatt (München; Uppsala, SE) |
|
|
Diskussion |
|
(V1295) |
Soluble sortilin promotes vascular calcification and is post-translationally modified in patients with chronic kidney disease |
| |
|
V. Jankowski, G. Heine, J. Jankowski, N. Marx, C. Goettsch (Aachen, Homburg) |
|
|
Diskussion |